Syeda Asiya Butool1*, Syed Murtuza Kirmani2, Shyam Agrawal1 Sandhya Gananjay Salve1 and Nitin Kararia3
1Department of Conservative Dentistry and Endodontics. MDS Nims University
Jaipur, Rajasthan, India
2Department of Anesthesia DNB, Yashoda Hospital, India
3Department of Conservative Dentistry and Endodontics, Nims University Jaipur, Rajasthan, India
*Corresponding Author: Syeda Asiya Butool, Department of Conservative Dentistry and Endodontics, NIMS University, Jaipur, India.
Received: June 15, 2022; Published: August 16, 2022
Mucormycosis is a fungus that is caused by mucormycetes, a type of mould with environmental contact with its spores. The entry of fungus into the body is through the skin which is injured or cut., it can develop on the skin. It also erodes face structures and travels across the respiratory tract. It is angioinvasive caused by the fungus Mucorales. It is most frequently encountered in immunocompromised patients. Following covid 19 second wave, there is a rapid increase in mucormycosis incidence in post-covid patients in India. If not treated early on, this disease appears to be fatal.
This review article seeks to provide a quick overview of the etiology, pathogenesis, risk factors, dos and don'ts, as well as recent breakthroughs in Mucormycosis diagnostic and therapeutic procedures.
Keywords: Mucormycosis; Covid 19; Diabetes
Citation: Syeda Asiya Butool., et al. “Mucormycosis during Covid 19: A Review Article".Acta Scientific Medical Sciences 6.9 (2022): 58-62.
Copyright: © 2022 Syeda Asiya Butool., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.